239 related articles for article (PubMed ID: 31065073)
1. Specific targeting of PKCδ suppresses osteoclast differentiation by accelerating proteolysis of membrane-bound macrophage colony-stimulating factor receptor.
Kim MY; Lee K; Shin HI; Jeong D
Sci Rep; 2019 May; 9(1):7044. PubMed ID: 31065073
[TBL] [Abstract][Full Text] [Related]
2. Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.
Lee K; Kim MY; Ahn H; Kim HS; Shin HI; Jeong D
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946669
[TBL] [Abstract][Full Text] [Related]
3. Neuromedin B and its receptor silencing suppresses osteoclast generation by modulating precursor proliferation via M-CSF/c-Fms/D-type cyclins.
Yeo CE; Kang WY; Seong SJ; Cho S; Lee HW; Yoon YR; Kim HJ
Exp Cell Res; 2017 Oct; 359(1):112-119. PubMed ID: 28780306
[TBL] [Abstract][Full Text] [Related]
4. The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.
Watanabe K; Hirata M; Tominari T; Matsumoto C; Fujita H; Yonekura K; Murphy G; Nagase H; Miyaura C; Inada M
J Biol Chem; 2016 Sep; 291(40):20891-20899. PubMed ID: 27539855
[TBL] [Abstract][Full Text] [Related]
5. Rab11A Functions as a Negative Regulator of Osteoclastogenesis through Dictating Lysosome-Induced Proteolysis of c-fms and RANK Surface Receptors.
Okusha Y; Tran MT; Itagaki M; Sogawa C; Eguchi T; Okui T; Kadowaki T; Sakai E; Tsukuba T; Okamoto K
Cells; 2020 Oct; 9(11):. PubMed ID: 33142674
[TBL] [Abstract][Full Text] [Related]
6. c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.
He Y; Rhodes SD; Chen S; Wu X; Yuan J; Yang X; Jiang L; Li X; Takahashi N; Xu M; Mohammad KS; Guise TA; Yang FC
PLoS One; 2012; 7(11):e46900. PubMed ID: 23144792
[TBL] [Abstract][Full Text] [Related]
7. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
Kimura K; Kitaura H; Fujii T; Hakami ZW; Takano-Yamamoto T
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):219-27. PubMed ID: 22067001
[TBL] [Abstract][Full Text] [Related]
8. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
Ohno H; Kubo K; Murooka H; Kobayashi Y; Nishitoba T; Shibuya M; Yoneda T; Isoe T
Mol Cancer Ther; 2006 Nov; 5(11):2634-43. PubMed ID: 17121910
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
[TBL] [Abstract][Full Text] [Related]
10. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
11. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
[TBL] [Abstract][Full Text] [Related]
12. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
13. Tyrosines 559 and 807 in the cytoplasmic tail of the macrophage colony-stimulating factor receptor play distinct roles in osteoclast differentiation and function.
Feng X; Takeshita S; Namba N; Wei S; Teitelbaum SL; Ross FP
Endocrinology; 2002 Dec; 143(12):4868-74. PubMed ID: 12446614
[TBL] [Abstract][Full Text] [Related]
14. Distinctive and selective route of PI3K/PKCα-PKCδ/RhoA-Rac1 signaling in osteoclastic cell migration.
Kim JM; Kim MY; Lee K; Jeong D
Mol Cell Endocrinol; 2016 Dec; 437():261-267. PubMed ID: 27576187
[TBL] [Abstract][Full Text] [Related]
15. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of syndecan ectodomains and N-desulfated heparins on osteoclastogenesis via direct binding to macrophage-colony stimulating factor.
Kim JM; Lee K; Kim MY; Shin HI; Jeong D
Cell Death Dis; 2018 Nov; 9(11):1119. PubMed ID: 30389911
[TBL] [Abstract][Full Text] [Related]
18. Receptor activator of nuclear factor-kappaB is induced by a rottlerin-sensitive and p38 MAP kinase-dependent pathway during monocyte differentiation.
Kang HS; Park EK; Kim KH; Park JY; Choi JY; Shin HI; Jun CD; Kang SS; Kim SY
Mol Cells; 2004 Jun; 17(3):438-45. PubMed ID: 15232218
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis.
Baud'huin M; Renault R; Charrier C; Riet A; Moreau A; Brion R; Gouin F; Duplomb L; Heymann D
J Pathol; 2010 May; 221(1):77-86. PubMed ID: 20191615
[TBL] [Abstract][Full Text] [Related]
20. Selective regulation of osteoclast adhesion and spreading by PLCγ/PKCα-PKCδ/RhoA-Rac1 signaling.
Kim JM; Lee K; Jeong D
BMB Rep; 2018 May; 51(5):230-235. PubMed ID: 29301608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]